Results for “SWEDEN” — Page 7

PubMed2000

Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in Russia and Sweden.

BACKGROUND AND PURPOSE: Stroke is declining in most of the western and northern European countries, whereas no such decline is seen in eastern Europe. The aim of this study was to investigate trends in stroke attack rates and 28-day case fatality and risk factor levels in Novosibirsk, Siberia, and northern Sweden during 1987-1994. METHODS: Within the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) Project, acute stroke events and 28-day case fatality were registered in a standardized way in men and women aged 35 to 69 years. Cardiovascular risk factors were monitored in randomly selected men and women in the group aged 35 to 64 years in 1985-1986 and 1994-1995. RESULTS: Stroke attack rates increased significantly from 430 per 100 000 to 660 (P=0.005) in men in Novosibirsk and from 298 to 500 (P=0.02) in women. In northern Sweden, stroke attack rates varied between 244 and 303 per 100 000 in men and from 117 to 157 in women, with a small increasing trend in women (P=0.03). The mortality rates were 5 times higher in Novosibirsk, and the case fatality was significantly lower in northern Sweden (P=0.0001). The risk factor surveys showed significantly higher blood pressure, overweight, and more smoking men in Novosibirsk, while northern Sweden had higher cholesterol levels and more smoking women. Most risk factors showed stable or improving patterns over time. CONCLUSIONS: Large differences in both attack rates and case fatality account for the large and widening gap in stroke mortality between Russia and Sweden. A higher prevalence of hypertension in Russia may explain much of the differences in stroke occurrence. In Russia, a marked increase in attack rates has occurred despite stable or improving patterns of conventional cardiovascular risk factors.

Adult↗

PubMed2000

Health care experiences and beliefs of elderly Finnish immigrants in Sweden.

PURPOSE: To elucidate the experiences and beliefs of care of elderly Finnish immigrants living in Sweden (Sweden-Finns) in order to gain an understanding of the role ethnic background plays in these experiences and beliefs. DESIGN: 39 elderly Sweden-Finns living in Stockholm were interviewed. The data were analysed hermeneutically. RESULTS: On a surface level, the care in Sweden was culturally congruent to elderly Sweden-Finns' experiences and beliefs of care. However, care in Finland and the care providers with Finnish background were regarded as superior to Swedish caregivers, giving a deeper sense of familiarity and trust in anticipation of good care. IMPLICATIONS FOR PRACTICE: Culturally appropriate care with care providers sharing the same ethnic background is important for ethnic elderly persons in enabling familiarity and trust between staff and patients.

Age Factors↗

PubMed1982

Variations between and within countries in hospital care for peptic ulcer. A comparison between Denmark and Sweden.

The present study tries to examine variations in utilization rates for hospital care for ulcer disease between and within Denmark and Sweden. The focus is on how utilization rates differ but an attempt is also made to explain why regional differences occur. Hospital patient statistics from both countries show that ulcer disease accounts for 35% more bed-days per 100000 inhabitants in Denmark than in Sweden. The main source for this difference is duodenal ulcer, where the number of bed-days is 63% higher in Denmark. The differences in length of stay are negligible and the numbers of surgical operations are about the same in the two countries. The greater utilization of hospital resources in Denmark is explained mainly by the fact that more medical cases are treated as in-patients in Denmark than in Sweden. Neither mortality rates nor other data support the hypothesis that the incidence of duodenal ulcer is higher in Denmark than in Sweden. The difference between Denmark and Sweden widens when utilization rates are adjusted for differences in the age structure of the population in the two countries. There are wide variations in utilization rates between regions within both countries. The findings support the hypothesis that the intertemporal change in the technology for management of ulcer disease is one of the main reasons for variations between and within countries.

Denmark↗

PubMed2006

Are there differences in all-cause and coronary heart disease mortality between immigrants in Sweden and in their country of birth? A follow-up study of total populations.

BACKGROUND: Mortality from cardiovascular diseases is higher among immigrants than native Swedes. It is not clear whether the high mortality persists from the country of birth or is a result of migration. The purpose of the present study was to analyse whether all-cause and coronary heart disease mortality differ between immigrants in Sweden and in the country of birth. METHODS: Two cohorts including the total population from Swedish national registers and WHO were defined. All-cause and CHD mortality are presented as age-adjusted incidence rates and incidence density ratios (IDR) in eight immigrant groups in Sweden and in their country of birth. The data were analysed using Poisson regression. RESULTS: The all-cause mortality risk was lower among seven of eight male immigrant groups (IDR 0.39-0.97) and among six of eight female immigrant groups (IDR 0.42-0.81) than in their country of birth. The CHD mortality risk was significantly lower in male immigrants from Norway (IDR = 0.84), Finland (IDR = 0.91), Germany (IDR = 0.84) and Hungary (IDR = 0.59) and among female immigrants from Germany (IDR = 0.66) and Hungary (IDR = 0.54) than in their country of birth. In contrast, there was a significantly higher CHD mortality risk in male immigrants from Southern Europe (IDR = 1.23) than in their country of birth. CONCLUSION: The all-cause mortality risk was lower in the majority of immigrant groups in Sweden than in their country of birth. The differences in CHD mortality risks were more complex. For countries with high CHD mortality, such as Finland and Hungary, the risk was lower among immigrants in Sweden than in their country of birth. For low-risk countries in South Europe, the risk was higher in immigrants in Sweden than in South Europe.

Age Distribution↗

PubMed2001

Antibacterial drugs prescribed for dogs and cats in Sweden and Norway 1990-1998.

The usage of veterinary antibacterial drugs in dogs and cats in Sweden and Norway for the period 1990-1998 was investigated by use of drug wholesalers' statistics. Additionally, usage of human antibacterial drugs in these species in Sweden was investigated by use of prescription data for the period 1996-1998. On average, more than 50% of the prescribed veterinary antibacterials in Sweden were beta-lactam antibiotics. In Norway, about 75% of the preparations prescribed for dogs and cats contained sulfonamides and trimethoprim. Furthermore, the prescription data from Sweden showed a reduced usage of human antibacterials prescribed for dogs and cats since the beginning of the 1980s. Approximately 20% of the prescribed packages for dogs in the years 1996-1998 were human approved drugs. The corresponding figure for cats was 13%. The differences between the countries in the choice of antibacterial drugs can be explained by differences in the availability of approved preparations during the study period. The consumption of veterinary antibacterials in dogs and cats in Sweden during the period was in the range of 3% to 8% of the total use of veterinary antibacterials. The corresponding figures in Norway were in the range of 3% to 7%. It is of vital importance to study usage patterns of antibacterial drugs in dogs and cats in surveillance and control of bacterial resistance, but also in discussions of therapeutic appropriateness. Therefore, further research is needed in this area.

Animals↗

PubMed2003

Management of chronic leg ulcers by nurses working in the community in Sweden and the UK.

OBJECTIVE: This study compared the management of chronic leg ulcers by nurses in community, primary health care and nursing home settings in Kronoberg, Sweden, and East Riding, UK. METHOD: A questionnaire was sent to all nurses in the two areas enquiring about their occupational background, leg ulcer management, resource utilisation and education and training. It also asked about their preferred treatment choices for four types of chronic leg ulcers described in case studies. Response rates of 50% (UK) and 54% (Sweden) were achieved. RESULTS: Nurses in the UK undertook diagnostic investigations of non-healing leg ulcers as part of the initial assessment, whereas in Sweden these were undertaken by physicians. In Sweden daily dressing changes were more frequent and often involved nurse auxiliaries. Patients and relatives almost never participated in dressing changes in the two countries. Sodium chloride was the most commonly used cleansing agent in the UK, as opposed to warm water in Sweden. The use of antibacterial/antiseptic dressings and antibiotics was more frequent in the UK. Nurses there also used scientific and professional literature more frequently. Swedish nurses experienced more problems in obtaining new information. CONCLUSION: Differences exist between the two countries in leg ulcer management. These may be related to differences in the health-care systems, staff training and attitudes to evidence-based practice.

Chronic Disease↗

PubMed1993

Understanding the pattern of support for the elderly: a comparison between Israel and Sweden.

Cross-cultural comparison can offer critical input to analyses of the interplay between formal and informal services for the elderly. Israel and Sweden have very different population structures and represent different points on the spectrum of welfare state development: Sweden has a much higher percentage of elderly, a less traditional family structure, and a much more developed system of public support. In addition, there are thought to be different attitudes toward family ties, with a less family-oriented value structure in Sweden. The natural question is to what extent these differences translate into differences in the extent and nature of family support for the elderly. In this article, family structure, living arrangements, disability rates, and formal and informal sources of help in Sweden and Israel are compared at various points in time. While there is a greater rate of formal service provision in Sweden and some substitution for family support seems to have occurred, informal care has nevertheless remained important. In both countries, residential patterns are critical: it is when the elderly live alone that the formal system has tended to replace the family. The rate of institutionalization is particularly important in determining the rate of disabled elderly requiring care, both formal and informal, in the community.

Aged↗

PubMed2004

Demographic analysis of the variation in the rates of multiple maternities in Sweden since 1751.

To elucidate the causes and mechanisms of twinning and higher multifetal maternities, we have taken advantage of the statistical sources of Sweden, where continuous statistics for the whole population are the oldest available. We found strong secular and regional fluctuations. The rates of multiple maternities were the highest during the last three decades of the 18th century, when the twinning rate was more than 17 per 1,000, the triplet rate was more than 3 per 10,000, and the quadruplet rate was almost 7 per 1 million maternities. During 1849-1873 the twinning rate in Sweden was 14.2 per 1,000, but this rate showed great regional differences, being 18.0 per 1,000 on the island of Gotland and 12.6 per 1,000 in the county of Alvsborg. During this period the twinning rate in the countryside in the county of Stockholm was 20.4, but in the city of Stockholm it was only 14.1 per 1,000. In Sweden after the 1930s there was a marked decrease in the twinning rate, which by the 1960s had fallen to only about half of what it had been two centuries earlier. The corresponding reductions for triplet and quadruplet rates were about 75%. The aim of this paper was to study the temporal and regional variations in multiple maternities in Sweden from 1751 to 1960 based on demographic and some socioeconomic data for the counties. We confirmed our earlier studies that maternal age and parity cannot satisfactorily explain the secular and regional differences in the twinning rates. In contrast to studies in France (1901-1968), we found no unequivocal association between the twinning rates and the crude birth rates. The correlation coefficients between the twinning rate and the crude birth rate showed statistically significant regional and temporal variations. After eliminating the temporal trends, regional differences in the correlation coefficients remained. The twinning rates for the counties seem to converge toward a common low level, 10-12 per 1,000. The observed convergence toward relatively similar levels may be caused by the increased matrimonial migration distances and decreased endogamy of the citizens as a consequence of better communications. The increased urbanization and industrialization that started in the last decades of the 19th century broke up the old static agrarian isolates and caused Sweden, within 2-3 generations, to develop from a poor nation to one of the most prosperous in the world. A more urban and affluent lifestyle, a better diet, and increased stress and sedentary occupations may have reduced the physical capacity of mothers to carry gestations with multiple embryos or fetuses to completion.

Demography↗

PubMed1996

Potentially avoidable perinatal deaths in Denmark and Sweden 1991.

BACKGROUND: Since 1950 the perinatal mortality has been significantly higher in Denmark than in Sweden. In 1991 the rate in Denmark was 8.0/1000 deliveries compared to 6.5/1000 in Sweden. An international audit was designed to investigate whether the perinatal death rates in the two countries to some extent could reflect differences in the quality of care, indicated by the numbers of perinatal deaths in categories of potentially avoidable deaths. MATERIAL AND METHODS: Medical records of 97% of all perinatal deaths in 1991 in the two countries were analyzed. A new classification focusing on potential avoidability from a health services perspective was elaborated at a Nordic-Baltic workshop, using the variables: time of death in relation to admission and delivery, fetal malformation, gestational age, growth-retardation and Apgar score at 5 min. RESULTS: Rates of perinatal deaths of malformed infants (0.00195 and 0.00145) and intrapartum deaths of non-malformed infants (0.00042 and 0.00019) was significantly higher in Denmark than in Sweden. CONCLUSION: Application of the Nordic-Baltic Perinatal Death Classification on perinatal deaths in Denmark and Sweden in 1991 raises the questions as to why the rate of perinatal death of malformed infants is higher in Denmark than in Sweden and whether intrapartum care in Denmark could be improved.

Cause of Death↗

PubMed1991

Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987.

Data concerning megavoltage equipment and use of megavoltage external beams in cancer management during 1987 in Denmark, Finland, Iceland, Norway, and Sweden were collected from all 37 centres serving a population of 23 million in these countries. Population per Linear Accelerator Equivalent (LAE) unit ranged from 0.30 million/LAE unit (Denmark) to 0.19 million/LAE unit (Sweden). The number of field treatments were 227,548 (Denmark), 259,917 (Finland), 10,426 (Iceland), 147,960 (Norway) and 490,126 (Sweden). The number of field treatments per million population per year ranged from 35,229 (Norway) to 58,438 (Sweden). The number of field treatments per LAE unit/year ranged from 13,192 (Denmark) to 9,546 (Norway). The fraction of cancer patients receiving megavoltage radiotherapy in 1987 out of all newly diagnosed cancer patients during 1987 was 24% in Denmark, 37% in Iceland, 25% in Norway, and 34% in Finland and Sweden. We conclude that Denmark and Norway probably did not provide adequate levels of radiotherapy for their cancer patients during 1987.

Denmark↗

PubMed1982

HLA B27 in the population of northern Sweden.

The frequency of HLA B27 in blood donors born in northern Sweden was found to be 16.6%. This was significantly higher than in southern Sweden or in caucasians generally, with the exception of Finland. A close genetic relationship has been found between the population of northern Sweden and the Finnish. The higher frequency of HLA B27 is particularly interesting in view of the finding of a higher incidence of rheumatic diseases in northern than in southern Sweden. We also found a surprisingly large number of patients with reactive arthritides and ankylosing spondylitis in the patient registers of the rheumatology department, which further indicated a genetic influence on rheumatic disorders in northern Sweden.

Arthritis, Reactive↗

PubMed1998

Genetic correlations among somatic cell scores, productive life, and type traits from the United States and udder health measures from Denmark and Sweden.

Sire genetic evaluations for protein yield, somatic cell score (SCS), productive life, and udder type traits from the US were correlated with sire evaluations for udder health from Denmark and Sweden and then the correlations were adjusted for accuracies to approximate genetic correlations. Traits from Denmark and Sweden included somatic cell count (SCC) and clinical mastitis from single-trait analyses. In addition, evaluations for clinical mastitis from Denmark and Sweden were regressed on US traits to test for quadratic relationships. Information from 85 bulls with US and Danish evaluations (77 with US type) and from 80 bulls with US and Swedish evaluations (79 with US type) was used to calculate correlations. Genetic correlations of US protein yield with Danish and Swedish SCC and clinical mastitis were all unfavorable (-0.09 to -0.32). Genetic correlations of US productive life with Danish and Swedish SCC and clinical mastitis were all favorable (0.06 to 0.59). Genetic correlations between US SCS and Danish SCC and between US SCS and Swedish SCC were -0.87 and -0.99, respectively (favorable). Genetic correlations between US SCS and Danish clinical mastitis and between US SCS and Swedish clinical mastitis were -0.66 and -0.49, respectively (favorable). The US type traits that had the largest correlations with clinical mastitis from Denmark and Sweden, respectively, were udder composite (0.26, 0.47), udder depth (0.45, 0.52), and fore udder attachment (0.31, 0.34). In general, quadratic regressions indicated little nonlinearity between clinical mastitis and the US traits. Specifically, the US bulls with the lowest predicted transmitting abilities for SCS had the most favorable rates of daughter clinical mastitis in Denmark and Sweden. Selection for increased productive life, lower SCS, and more shallow udders should improve mastitis resistance.

Animals↗

PubMed2000

Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.

BACKGROUND: The timeliness with which national regulatory agencies approve new drugs for marketing affects health care professionals and patients. An unnecessarily long approval process delays access to new medications that may improve patients' health status. The author compared drug approval times in Canada, Australia, Sweden, the United Kingdom and the United States. METHODS: Application and approval dates of new chemical or biological substances (excluding diagnostic products, and new salts, esters, dosage forms and combinations of previously approved substances) approved for marketing in the 5 countries from January 1996 to December 1998 were requested from the relevant pharmaceutical companies. Data on new drug approvals during the study period were also obtained from the national drug regulatory agencies in Canada, Australia and Sweden and from publications of the US Food and Drug Administration. RESULTS: A total of 219 new drugs were identified as being approved in at least one of the countries during the study period: 23 (10.5%) in all 5 countries, 23 (10.5%) in 4, 27 (12.3%) in 3, 42 (19.2%) in 2, and 104 (47.5%) in 1 country. By individual nation, 97 drugs were identified as being approved in Canada, 94 in Australia, 107 in Sweden, 55 in the UK and 123 in the US. Approval times in Canada and Australia were similar (medians 518 and 526 days respectively), but both countries had significantly longer approval times than Sweden (median 371 days), the UK (median 308 days) and the US (median 369 days). This pattern was consistent across all 3 years and for the 23 new drugs approved in all 5 countries during the 3-year period. Median approval times in Canada were similar in all of the reviewing divisions of Health Canada's Therapeutic Product Program (539-574 days) except the Central Nervous System Division (428 days) and the Bureau of Biologics and Radiopharmaceuticals (698 days). INTERPRETATION: Median drug approval times during 1996-1998 decreased by varying amounts from the 1995 values in all 5 countries. However, the median approval time in Canada continues to be significantly longer than the times achieved in Sweden, the UK and the US, and it remains considerably longer than Canada's own target of 355 days for all new drugs.

Australia↗

PubMed1999

Improving return-to-work strategies in the United States disability programs, with analysis of program practices in Germany and Sweden.

The General Accounting Office (GAO) has made recommendations for improving the disability programs by citing practices that have been successful in Germany, Sweden, and the private sector. This issue is important in the United States because the number of disability beneficiaries is growing rapidly, program costs are increasing proportionately, and few disability recipients are leaving the disability rolls to resume work activity. GAO points out that the estimated lifetime savings for removing an additional 1 percent of the disabled beneficiaries from the rolls of the Disability Insurance (DI) and the Supplemental Security Income (SSI) programs each year will ultimately reach $3.0 billion. GAO cites three specific practices as showing the most promise for returning the disabled to work. They are (1) intervening as soon as possible after a disabling event to promote and facilitate return to work, (2) identifying and providing necessary return-to-work assistance and managing cases to achieve return-to-work goals, and (3) structuring cash and health benefits to encourage people with disabilities to return to work. This article examines these suggestions to improve the rate of rehabilitation of disabled workers using research by experts on return-to-work practices in Germany, Sweden, and the United States. Experts caution that any consideration of borrowing practices from other countries needs to take into account the unique economic, social, and political elements in each country. Although other countries appear to be very successful in their rehabilitation programs, practices that are successful in one country may not necessarily work well in another. Countries have different definitions of disability and payment structures. The existence of temporary and partial awards in Germany and Sweden may ensure a number of easily rehabilitated individuals, while the U.S. vocational rehabilitation (VR) agencies have been mandated to focus on only the most severely disabled individuals. Public expenditures for vocational rehabilitation, work for the disabled, and disability benefits are much higher as a percentage of gross domestic product in Germany and Sweden than they are in the United States. Compared with the United States, Germany spent twice as much for VR, and Sweden spent 2.6 times more. Impediments to GAO's suggestions include divergent goals of the Social Security program and VR agencies, lack of availability of VR services, the timing of VR referral (which is significantly later than the onset of the disability), and little incentive for return to work built into the payment structure. The Work Incentives Improvement Act of 1999 is currently being considered by a Congressional conference committee. The bill would establish a Ticket to Work and Self-Sufficiency program and would require or authorize the Social Security Administration to demonstrate and evaluate different ways of encouraging return to work. In designing these demonstrations, early intervention after a potentially disabling illness or injury is an approach that merits serious attention.

Persons with Disabilities↗

PubMed2000

["Sound, unsound around the Sound". A congress report on health differences between Denmark and Sweden].

During the past 10 years, researchers on both sides of The Sound in the so-called Oresund region have worked together to analyze the causes of the observed differences in life expectancy between Denmark and Sweden. The region includes Copenhagen and North Zealand and the county of Scania in southern Sweden, with Malmö as its largest city. Both Denmark and Sweden held top rankings among OECD-countries in 1970 regarding life expectancy at birth. In 1990 Denmark had fallen to a bottom ranking, while Sweden was still at the top. At a scientific meeting in Malmö on January 26-27, 2000, some 60 presentations were made concerning differences and similarities in health measures on the two sides of the sound which divides the two countries. On the Swedish side, life expectancy is 3-4 years longer than on the Danish side. Paramount among explanations are higher mortality figures due to smoking and alcohol-related diseases on the Danish side, both in men and women (most pronounced). Minor contributions to the differences are suicides and traffic accidents. Historically, Denmark and Sweden have much in common. Until 1658, Scania, the Swedish county to the east of The Sound was part of Denmark. During the past 150 years rather impressive cultural differences have developed. Smoking prevalence and alcohol consumption are more than twice as high on the Danish side of the sound. In coming years, researchers, representatives for the health service systems and others will work together in order to prevent disease and promote health in the Oresund region. The conference was arranged by the Medicon Valley Academy, an EU-supported enterprise seeking to stimulate research and development within the health sector in the Oresund region (also known as Medicon Valley).

Alcohol Drinking↗

PubMed2000

["Sound and unsound around the Sound". A congress report on health differences between Denmark and Sweden].

During the past 10 years, researchers on both sides of The Sound in the so-called Oresund region have worked together to analyze the causes of the observed differences in life expectancy between Denmark and Sweden. The region includes Copenhagen and North Zealand and the county of Scania in southern Sweden, with Malmö as its largest city. Both Denmark and Sweden held top rankings among OECD-countries in 1970 regarding life expectancy at birth. In 1990 Denmark had fallen to a bottom ranking, while Sweden was still at the top. At a scientific meeting in Malmö on January 26-27, 2000, some 60 presentations were made concerning differences and similarities in health measures on the two sides of the sound which divides the two countries. On the Swedish side, life expectancy is 3-4 years longer than on the Danish side. Paramount among explanations are higher mortality figures due to smoking and alcohol-related diseases on the Danish side, both in men and women (most pronounced). Minor contributions to the differences are suicides and traffic accidents. Historically, Denmark and Sweden have much in common. Until 1658, Scania, the Swedish county to the east of The Sound was part of Denmark. During the past 150 years rather impressive cultural differences have developed. Smoking prevalence and alcohol consumption are more than twice as high on the Danish side of the sound. In coming years, researchers, representatives for the health service systems and others will work together in order to prevent disease and promote health in the Oresund region. The conference was arranged by the Medicon Valley Academy, an EU-supported enterprise seeking to stimulate research and development within the health sector in the Oresund region (also known as Medicon Valley).

Alcohol Drinking↗

PubMed2000

New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.

In two previous studies, the times required to approve new drugs in Canada, Australia, Sweden, the United Kingdom and the United States during the periods 1992 to 1995 and 1996 to 1998 were compared. However, during each of these two periods, only a fraction of the drugs that were approved in any of the countries were approved in all of them. Because an analysis based solely on drugs approved in all the countries would provide additional information, data from the previous studies have been used to compare drugs approved in each of Canada, Australia, Sweden and the United States during the period 1992 to 1998. In addition, applications that received a 'priority' or a 'standard' review by the United States Food and Drug Administration were analyzed separately to determine whether differences between the countries diminished for drugs considered to be of potentially greater therapeutic value. For the 87 drugs identified as being approved for marketing in all four countries during the period 1992 to 1998, approval times in Canada and Australia were not significantly different, but both Canada and Australia had significantly longer times than those of the United States and Sweden (P<0.001). Of the 87 drugs, 37 (43%) received a priority review in the United States. In both the priority and standard review categories, the Australian and Canadian median approval times were significantly longer than those in Sweden and the United States. The results demonstrate that, in general, both priority and standard new drug applications are reviewed more expeditiously in Sweden and the United States than in Canada. Canadian patients continue to experience delayed access to potentially valuable medicines.

Australia↗

PubMed2000

[Sound and unsound around the Sound. A congress report on health differences between Denmark and Sweden].

During the past 10 years, researchers on both sides of The Sound in the so-called Oresund region have worked together to analyze the causes of the observed differences in life expectancy between Denmark and Sweden. The region includes Copenhagen and North Zealand and the county of Scania in southern Sweden, with Malmö as its largest city. Both Denmark and Sweden held top rankings among OECD-countries in 1970 regarding life expectancy at birth. In 1990 Denmark had fallen to a bottom ranking, while Sweden was still at the top. At a scientific meeting in Malmö on January 26-27, 2000, some 60 presentations were made concerning differences and similarities in health measures on the two sides of the sound which divides the two countries. On the Swedish side, life expectancy is 3-4 years longer than on the Danish side. Paramount among explanations are higher mortality figures due to smoking and alcohol-related diseases on the Danish side, both in men and women (most pronounced). Minor contributions to the differences are suicides and traffic accidents. Historically, Denmark and Sweden have much in common. Until 1658, Scania, the Swedish county to the east of The Sound was part of Denmark. During the past 150 years rather impressive cultural differences have developed. Smoking prevalence and alcohol consumption are more than twice as high on the Danish side of the sound. In coming years, researchers, representatives for the health service systems and others will work together in order to prevent disease and promote health in the Oresund region. The conference was arranged by the Medicon Valley Academy, an EU-supported enterprise seeking to stimulate research and development within the health sector in the Oresund region (also known as Medicon Valley).

Alcohol Drinking↗